News | News By Subject | News by Disease News By Date | Search News

Lupus Erythematosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Finding a Complementary Secondary Endpoint in Lupus Clinical Trials     1/10/2017
With Little Fanfare, Biogen (BIIB) Sneaks Lupus Drug Into a Phase I Trial     7/15/2016
Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK)'s Lupus Drug Also Performs Well in Late Stage Study     11/11/2015
AstraZeneca PLC (AZN)'s Lupus Drug Anifrolumab Meets Goals in Mid-Stage Study     11/10/2015
BIO2015 EXCLUSIVE: BioSpace (DHX)’s Insider Profile of Neovacs SA     7/9/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
23andMe is Sharing Users' Data Again, This Time With Pfizer (PFE)     1/15/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Trial Failures Force Eli Lilly and Company (LLY) To Terminate Development Of Tabalumab     10/6/2014
AstraZeneca PLC (AZN) Touts Success In 2 Phase 2 Studies     5/15/2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Anti-Inflammatory Drug Pact Hits A Roadblock     3/4/2014
Rigel Pharmaceuticals, Inc. (RIGL)'s Skin Drug Misses Primary Endpoint, Study Discontinued     10/25/2013
Healthcare Watchdog to Reconsider GlaxoSmithKline (GSK) Drug Benlysta Following Drugmaker's Appeal     9/10/2012
Primary Goal Not Met in Anthera Pharmaceuticals, Inc. (ANTH)'s Lupus Drug Study     6/28/2012

News from Around the Web
New Genetic Risk Factors of Lupus Found in Study of African-American Women, Boston University Study     6/27/2011
Lupus, Rheumatoid Arthritis May Raise Risk of Abnormal Heart Rhythm, University of Arkansas for Medical Sciences Study     5/9/2011
First Lupus Breakthrough in 50 Years, Monash University Study Reveals     5/6/2011
Study Identifies Genetic Variation Linked to Lupus in Asian Men, University of California, Los Angeles (UCLA) Study     8/24/2010
Lupus in Newborns Predicts Heart Block in Siblings, New York University Study     4/9/2010
Novel DNA Vaccine Leads To Kidney Damage Prevention In Systemic Lupus Erythematosus Models, Universidad de Guadalajara Study     6/18/2009
Blocked Protein Prevents Lupus In Mouse Model, The Jackson Laboratory And National Institutes of Health (NIH) Study     1/22/2009
New Inhibitor Drug Seen For Arthritis, Lupus, Australian Researchers Report in Immunology and Cell Biology     11/25/2008
Abnormal 'Editing' Of Gene Messages May Be A Cause Of Lupus, Wake Forest University Study     5/21/2008
Overabundance of Immune Cells Might Trigger Lupus     2/15/2008
New Genetic Mutation That Halts The Development Of Lupus Discovered By Scripps Research Institute     1/21/2008
Gene Studies Home In On Lupus Cause     1/21/2008
New Approach for Attacking Lupus Identified     12/17/2007
Lupus Gene Finding Prompts Call for More DNA Samples. Wellcome Trust Sanger Institute Study     12/3/2007
Existing Drugs Show Promise for Treating End-Stage Renal Disease in Lupus     11/12/2007

Press Releases
ImmuPharma plc (IMM.L) Release: Company Update On Lupuzor Pivotal Phase III Study Full Analysis Of Patient Recruitment     1/25/2017
Immunovia Release: Company Announces The First Data Exceeding 90% Accuracy In Distinguishing Systemic Lupus Erythematosus (SLE) From Other Autoimmune Diseases In A New Study     1/16/2017
Mallinckrodt (MNK) Release: Study Addresses Possible Impact Of H.P. Acthar Gel On Use Of Corticosteroids Among Patients With Rheumatoid Arthritis, Lupus, And Dermatomyositis/Polymyositis     11/18/2016
GlaxoSmithKline (GSK)'s Benlysta (Belimumab) Shows Sustained Benefits In Patients With SLE     11/16/2016
Merck KGaA (MKGAF.PK)'s Atacicept Flops in Phase IIb Lupus Study But Firm Remains Upbeat     11/15/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Lupus     11/15/2016
GlaxoSmithKline (GSK) Announces Positive Results In Fourth Consecutive Pivotal Trial Of Benlysta (Belimumab) In SLE     11/14/2016
Neovacs Enrolls The First U.S. Patient In Phase IIb Study Of Ifna Kinoid For Treatment Of Systemic Lupus Erythematosus (SLE)     11/7/2016
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Presents Phase II Data On The Safety And Efficacy Of Atacicept At The 2016 ACR/ARHP Annual Meeting     11/2/2016
Lupus Research Alliance Announces Published Data Showing Effective Approach To Drug Repositioning     9/27/2016
XTL Biopharma (XTLB) Announces The European Patent Office Has Issued A Patent For Its Lupus Drug hCDR1     9/7/2016
Resolve Therapeutics Announces Publication Of Clinical Data Demonstrating The Role Of Circulating RNA In Systemic Lupus Erythematosus     8/22/2016
XTL Biopharma (XTLB) Announces New Patent Filing In U.S. For Lupus Drug hCDR1     8/11/2016
Anthera Pharma (ANTH)Announces Completion Of Dosing In CHABLIS-SC1 Phase III Clinical Study With Blisibimod     8/4/2016
Anthera Provides Clinical Program Updates For Blisibimod And Sollpura     6/29/2016